US2020037875A1PendingUtilityA1

Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise

Assignee: DEXCOM INCPriority: May 18, 2007Filed: Oct 10, 2019Published: Feb 6, 2020
Est. expiryMay 18, 2027(~0.8 yrs left)· nominal 20-yr term from priority
A61B 5/14865A61B 5/14546A61B 5/14735A61B 5/14532A61B 5/6848A61B 5/7203A61B 5/1473A61B 5/00A61B 5/1486
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods of use involving sensors having a signal-to-noise ratio that is substantially unaffected by non-constant noise are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . A transcutaneous electrochemical glucose sensor configured for implantation in a host, the transcutaneous electrochemical glucose sensor comprising:
 a first portion configured to remain outside a body of the host during sensor use, wherein the first portion is configured to operably connect with sensor electronics; and   a second portion configured to be inserted inside the body of the host during sensor use, wherein the second portion comprises:
 a planar substrate; 
 a working electrode disposed over at least a portion of the planar substrate; 
 a membrane layer disposed over at least a portion of the working electrode; and 
 a reference electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor, 
   
     
     
         22 . The transcutaneous electrochemical glucose sensor of  claim 21 , wherein the membrane layer is configured to control a diffusion of glucose therethrough. 
     
     
         23 . The transcutaneous electrochemical glucose sensor of  claim 21 , wherein the membrane layer comprises polyurethane. 
     
     
         24 . The transcutaneous electrochemical glucose sensor of  claim 21 , wherein the transcutaneous electrochemical glucose sensor has a planar shape. 
     
     
         25 . The transcutaneous electrochemical glucose sensor of  claim 21 , wherein the reference electrode comprises silver and silver chloride. 
     
     
         26 . The transcutaneous electrochemical glucose sensor of  claim 21 , further comprising a counter electrode disposed at least in part on the second portion of the transcutaneous electrochemical glucose sensor.

Join the waitlist — get patent alerts

Track US2020037875A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.